Skip to main content

Table 3 Reporting of hepatitis screening in relation to demographic status, behavioural variables and HIV testing history according to sex

From: State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)

 

Men

Women

Percentage reporting hepatitis screening

Crude OR

Adjusted OR

Percentage reporting hepatitis screening

Crude OR

Adjusted OR

All

23.7 (22.1–25.3)

  

34 (32–36)

  

Demographic characteristics

 Age groups

  15 − 24 years

14.3 (11.9 − 17.1)

1

1

24.5 (21.6 − 27.6)

1

1

  25 − 49 years

27.7 (25.6 − 29.9)

2.29 (1.83 − 2.87)

1.33 (1.03 − 1.71)

41 (38.4 − 43.6)

2.14 (1.79 − 2.56)

1.36 (1.10 − 1.67)

  50 − 64 years

25.5 (22.3 − 28.9)

2.05 (1.59 − 2.64)

1.52 (1.13 − 2.03)

26.6 (23.8 − 29.6)

1.12 (0.90 − 1.38)

1.29 (1.02 − 1.63)

 Socioeconomic status

  A/B

30.6 (27.4 − 34)

2.38 (1.81 − 3.13)

1.78 (1.34 − 2.37)

40.6 (36.9 − 44.5)

2.35 (1.89 − 2.94)

2.10 (1.66 − 2.68)

  C

22 (20 − 24.1)

1.52 (1.18 − 1.94)

1.14 (0.88 − 1.47)

34.4 (32 − 36.9)

1.80 (1.49 − 2.18)

1.56 (1.27 − 1.93)

  D/E

15.7 (12.9 − 18.9)

1

1

22.5 (19.8 − 25.5)

1

1

Sexual behaviour

 Age at initial intercourse

   < 15 years

28.1 (25.4 − 30.9)

1.32 (1.23 − 1.60)

1.32 (1.10 − 1.57)

33 (29.2 − 37.1)

0.83 (0.68 − 1.00)

 

   ≥ 15 years

22.8 (20.9 − 24.8)

1

1

37.4 (35.1 − 39.7)

1

 Sex with same sex, ever

  No

24.4 (22.6 − 26.1)

1

 

36.6 (34.5 − 38.9)

1

 

  Yes

30 (24.5 − 36.1)

1.33 (1.00 − 1.77)

 

38.6 (31.1 − 46.6)

1.08 (0.78 − 1.51)

 Condom use at last sexual intercourse

  Yes

24.6 (22.2 − 27.3)

1

 

38.2 (34.7 − 41.9)

1

 

  No

26.7 (24.3 − 29.2)

1.11 (0.93 − 1.35)

39.1 (36.4 − 41.7)

1.03 (0.87 − 1.23)

 Number sexual partners over the lifetime

   ≤ 10

21.7 (19.2 − 24.3)

1

 

42.1 (39.2 − 45)

1

 

   > 10

27.9 (25.4 − 30.6)

1.40 (1.16 − 1.69)

38.7 (33.8 − 43.9)

0.87 (0.70 − 1.09)

 Having casual partner, last 12 months

  No

27 (24.9 − 29.2)

1

 

39.7 (37.3 − 42.1)

1

 

  Yes

23.6 (21 − 26.4)

0.84 (0.70 − 0.99)

33.6 (28.8 − 38.7)

0.76 (0.61 − 0.96)

 Intravenous drugs, ever

  No

23.8 (22.2 − 25.5)

1

 

34 (32 − 36)

1

 

  Yes

19.9 (10.1 − 35.4)

0.80 (0.36 − 1.76)

29.7 (18 − 44.8)

0.82 (0.43 − 1.58)

 Tested for HIV, ever

  No/don’t know

13 (11.6 − 15.6)

1

1

16.5 (14.8 − 18.4)

1

1

  Yes

53.8 (50.4 − 57.1)

7.79 (6.46 − 9.39)

7.05 (5.82 − 8.53)

60.1 (57.1 − 63)

7.62 (6.44 − 9.00)

7.13 (5.97 − 8.54)

  1. The data in parentheses are 95 % CIs
  2. COR crude odds ratio, AOR adjusted odds ratio
  3. ... not statistically significant